Navigation Links
Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
Date:3/25/2013

EXTON, Pa., March 25, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceuticals issues, finds that, despite the 2012 launch of Medivation/Astellas Pharma's Xtandi (enzalutamide) for the treatment of docetaxel-pretreated metastatic castrate-resistant prostate cancer (mCRPC), surveyed oncologists report that Johnson & Johnson/Janssen Biotech/Janssen-Cilag's Zytiga continues to dominate the second-line mCRPC setting—although its share dropped marginally from Q3 2012 to Q1 2013. The patient share of Sanofi's Jevtana showed a marked decline over this time period as a result of Xtandi's availability, especially in the third line where Jevtana's patient share in Q1 2013 is half that of its reported share in Q3 2012. The findings are from the TreatmentTrends® Prostate Cancer (US) Q1 2013 report, in which 53 urologists and 51 medical oncologists were surveyed about their current and expected treatment practices for prostate cancer.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO )

"In the first-line symptomatic mCRPC setting, docetaxel still dominates treatment according to surveyed oncologists, despite the recent label extension of Zytiga for chemotherapy-naive mCRPC in December 2012," said Decision Resources Group Analyst Khurram Nawaz , M.Sc. "Nevertheless, surveyed oncologists indicate that Zytiga's patient share for first-line symptomatic mCRPC has almost doubled from Q3 2012 to Q1 2013. Interestingly, both surveyed urologists and oncologists indicate that Xtandi is also prescribed for first-line mCRPC patients, although this off-label use remains minimal due to perceived reimbursement challenges."

Surveyed physicians are most satisfied with Zytiga as a treatment for mCRPC; Dendreon's Pr
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Global Spinal Nonfusion Market to Grow to $1 Billion by 2017, Despite Challenges
2. Opportunities Exist Despite Challenges in Chinas API Market
3. Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market
4. According to New Survey, Most Men are Not Proactive about Their Health Despite the Desire to Live Long Lives
5. SafeCode Drug Technologies Initiating Activities to Commercialize its Recent Newly Acquired Technology of the Pain-Free Injection
6. Precision Optics Corporation, Inc. Operating Results for Six Months Ended December 31, 2012 and Recent Operating Activities
7. Vancouver General Hospital Deploys TRU-D Superbug Slayer to Battle Worst Season of Flu in Recent Memory
8. KemPharm Supports Recent FDA Recommendations for Hydrocodone-Containing Compounds and Abuse-Deterrent Opioids
9. Hologic to Showcase 3D Mammography and Other Recent Innovations in Healthcare at the 38th Arab Health Congress in Dubai
10. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
11. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)...   Cypher Genomics, Inc., the genome informatics ... Ravenel as chief technology officer. Ravenel has more ... and a proven track record of designing and architecting ... has been recognized as a top designer and architect ... industry-wide for delivering innovative products that operate at scale ...
(Date:10/1/2014)... 1, 2014   Royal Philips (NYSE: ... its eCareCoordinator and eCareCompanion telehealth applications have received ... Administration (FDA). A part of Philips Hospital to ... and eCareCompanion are focused on patient care within ... to be available through the cloud-based digital health ...
(Date:10/1/2014)... 1, 2014  CVS Health is thanking its 26,000 ... in changing the way health care is delivered to ... Company,s retail pharmacies, mail service pharmacies and specialty pharmacies ... company name to CVS Health to reflect our broader ... innovations needed to shape the future of health," said ...
Breaking Medicine Technology:Cypher Genomics Appoints J. Patrick Ravenel Chief Technology Officer 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3
... Aug. 30 Brothers blow the numbers away. ... short years ago and have never looked back. ... (Logo:   http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) (Logo:  http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO) ... provider of low cost ultrasound systems in the ...
... FALLS, N.Y., Aug. 30 Laerdal Medical has ... training since the company launched its famous Resusci ... extensive experience to bear as it launches its ... (Photo: http://photos.prnewswire.com/prnh/20100830/NY56743 ) (Photo: ...
Cached Medicine Technology:National Ultrasound Makes the Inc 5000 List for Third Year in a Row 2Laerdal Introduces SimMan Essential 2Laerdal Introduces SimMan Essential 3
(Date:10/1/2014)... October 01, 2014 Insuranceragents.info has ... a good life insurance plan for vulnerable family members. ... vulnerable family members. Providers in the family should always ... cause financial hardships for the rest of the family. ... policies. Families can benefit more from temporary coverage or ...
(Date:10/1/2014)... October 01, 2014 Phoseon Technology, the ... continues to expand the business worldwide. This rapid growth ... additional capacity for manufacturing efforts. The company has experienced ... five years and expects this growth to continue in ... technology gains worldwide adoption. , “We are very ...
(Date:10/1/2014)... A new genetic finding from Duke Medicine suggests that ... depression might also be hard-wired to gain weight when ... disease. , An estimated 13 percent of people, all ... and knowing this could help them reduce heart disease ... and stress management. , "Genetic susceptibility, psychosocial stress and ...
(Date:10/1/2014)... Jersey City, NJ (PRWEB) October 01, 2014 ... sticking with their intentions to lose weight and their dieting ... in unhealthy, fatty foods. Including hormone diet treatments ... not only allows patients to see fast and effective weight ... diet and begin forming healthy habits to maintain their weight ...
(Date:10/1/2014)... 2014 On Sept. 9, Chapín Coffee ... the Martha Stewart American Made Awards (MSAMAs), an annual ... country in the fields of crafts, design, food and ... a finalist in the MSAMAs, which celebrates entrepreneurs and ... improving local communities and changing the way we shop, ...
Breaking Medicine News(10 mins):Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2
... experimental vaccine developed by researchers at Cedars-Sinai Medical Center,s ... aggressive brain tumors and improves length of survival in ... presented in a poster session at the 47th Annual ... Patients with newly diagnosed glioblastoma multiforme, the most ...
... biologists at Cold Spring Harbor Laboratory (CSHL) have obtained ... an allosteric inhibitor in a subtype of the NMDA ... The newly discovered binding site -- a ... it is a potential target for drugs that can ...
... By Maureen Salamon HealthDay Reporter ... research in Illinois reveals that medical specialists refuse ... conditions six times more often than privately insured ... mothers of children with seven common health conditions ...
... , WEDNESDAY, June 15 (HealthDay News) -- Medical ... look beyond survival and plan for the future. But for ... researchers say. In fact, researchers from Penn State found ... each year in medical care costs than people who have ...
... 15, 2011 A University of Houston (UH) chemist who ... published papers in two high-impact journals this month. ... colleagues have developed two different materials that are both equally ... June issues of Chemical Communications ( ChemComm ) ...
... the journal Nature , scientists discovered an entirely new ... are significant because they may ultimately help researchers alter the ... dystrophy and many forms of cancer. The genetic ... tell a cell how to make a specific protein. Central ...
Cached Medicine News:Health News:Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors 2Health News:Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors 3Health News:CSHL structural biologists reveal novel drug binding site in NMDA receptor subunit 2Health News:Specialists Often Turn Away Kids With Public Insurance: Report 2Health News:Specialists Often Turn Away Kids With Public Insurance: Report 3Health News:Cancer Survivors Face High Health Costs Over Long Term: Report 2Health News:UH chemist developing materials to detect, repel E. coli 2Health News:Changing genetic 'red light' to green holds promise for treating disease 2Health News:Changing genetic 'red light' to green holds promise for treating disease 3
... sensitivity (threshold) testing provides clinically beneficial ... ophthalmic conditions. Dark adaptometry is useful ... retinal degenerations, senile miosis, high myopia, ... conditions, while whole-field scotopic sensitivity has ...
... The MFERG is available in conjunction with ... UTAS-E3000mf or EPIC-4000 or as a stand-alone ... visual electrodiagnostic test uses a software controlled ... to stimulate many areas of the retina ...
... Amplifier (UBA-4204) from LKC Technologies, ... amplification and complete electrical isolation ... problems of DC drifting, 50/60Hz ... make the amplifier ideal for ...
... to facilitate an arthrodesis, either by an ... cages allowing radicular compression by restoring the ... of the foramina, which in turn enhances ... major lumbar instabilities.,CC cages are made of ...
Medicine Products: